packageAclarubicin

aclarubicin

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Aclarubicin is an anthracycline antibiotic investigated as a cancer treatment, acting as a topoisomerase II inhibitor. It is considered investigational and is not authorised in the European Union.

Summary written by glm-5.3-flash from Wikidata Q4674302 and the WHO ATC classification; not checked by a person.

name:aclarubicin
ATC codes:L01DB04
DrugBank:DB11617
PubChem CID:451415
ChEBI:74619
Wikidata:Q4674302
formula:C42H53NO15
molar mass:811.878 g/mol (PubChem CID 451415)
logP:3.8 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown